Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice

Bo Ahrén, Ronald L. Gingerich, Peter J Havel

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The gut hormones, cholecystokinin (CCK) and truncated glucagon-like peptide 1 (GLP-1(7-36)amide or GLP-1) both stimulate insulin secretion and affect glucagon secretion in mice, but their effects on the secretion of other islet hormones have not been established in rodents. In the present study, we have examined the influence of the C-terminal octapeptide of CCK, CCK-8, and GLP-1 on the secretion of pancreatic polypeptide (PP) in the mouse by the use of a radioimmunoassay for rodent PP. Mice were injected intravenously with CCK-8 (doses in the range of 0.053-5.3 nmol/kg) or with GLP-1 (doses in the range of 1-32 nmol/kg) and blood was sampled at 2, 6 or 10 min after the injection. Controls were injected with saline. It was found that CCK-8 at 5.3 nmol/kg increases plasma levels of both PP and insulin when the sample was taken at 2 min, but not at 6 or 10 min, after injection. These effects were blocked by the selective CCKA-receptor antagonist, L-364,718 (2.4 μmol/kg). GPL-1 increased plasma insulin levels at 32 nmol/kg at 2 and 6 min after the injection, but plasma PP levels were unaltered. In conclusion, this study, using a newly developed radioimmunoassay for PP in rodents, shows that CCK-8 but not GPL-1 stimulates PP secretion in mice at does levels where both peptides stimulate insulin secretion. Furthermore, PP secretion in response to CCK-8 showed a similarity with that of insulin in terms of dose- and time-response characteristics as well as sensitivity to CCKA-receptor antagonism.

Original languageEnglish (US)
Pages (from-to)297-302
Number of pages6
JournalRegulatory Peptides
Volume59
Issue number3
DOIs
StatePublished - Nov 10 1995

Fingerprint

Pancreatic Polypeptide
Glucagon-Like Peptide 1
Cholecystokinin
Insulin
Rodentia
Plasmas
Injections
Radioimmunoassay
Devazepide
Hormones
Sincalide
Glucagon
Blood
cholecystokinin 8
Peptides

Keywords

  • Cholecystokinin
  • Glucagon-like peptide 1
  • Mouse
  • Pancreas
  • Pancreatic polypeptide secretion

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience
  • Neuroscience(all)

Cite this

Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice. / Ahrén, Bo; Gingerich, Ronald L.; Havel, Peter J.

In: Regulatory Peptides, Vol. 59, No. 3, 10.11.1995, p. 297-302.

Research output: Contribution to journalArticle

@article{171085e17dae45bda4a868d4c370099a,
title = "Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice",
abstract = "The gut hormones, cholecystokinin (CCK) and truncated glucagon-like peptide 1 (GLP-1(7-36)amide or GLP-1) both stimulate insulin secretion and affect glucagon secretion in mice, but their effects on the secretion of other islet hormones have not been established in rodents. In the present study, we have examined the influence of the C-terminal octapeptide of CCK, CCK-8, and GLP-1 on the secretion of pancreatic polypeptide (PP) in the mouse by the use of a radioimmunoassay for rodent PP. Mice were injected intravenously with CCK-8 (doses in the range of 0.053-5.3 nmol/kg) or with GLP-1 (doses in the range of 1-32 nmol/kg) and blood was sampled at 2, 6 or 10 min after the injection. Controls were injected with saline. It was found that CCK-8 at 5.3 nmol/kg increases plasma levels of both PP and insulin when the sample was taken at 2 min, but not at 6 or 10 min, after injection. These effects were blocked by the selective CCKA-receptor antagonist, L-364,718 (2.4 μmol/kg). GPL-1 increased plasma insulin levels at 32 nmol/kg at 2 and 6 min after the injection, but plasma PP levels were unaltered. In conclusion, this study, using a newly developed radioimmunoassay for PP in rodents, shows that CCK-8 but not GPL-1 stimulates PP secretion in mice at does levels where both peptides stimulate insulin secretion. Furthermore, PP secretion in response to CCK-8 showed a similarity with that of insulin in terms of dose- and time-response characteristics as well as sensitivity to CCKA-receptor antagonism.",
keywords = "Cholecystokinin, Glucagon-like peptide 1, Mouse, Pancreas, Pancreatic polypeptide secretion",
author = "Bo Ahr{\'e}n and Gingerich, {Ronald L.} and Havel, {Peter J}",
year = "1995",
month = "11",
day = "10",
doi = "10.1016/0167-0115(95)00081-L",
language = "English (US)",
volume = "59",
pages = "297--302",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice

AU - Ahrén, Bo

AU - Gingerich, Ronald L.

AU - Havel, Peter J

PY - 1995/11/10

Y1 - 1995/11/10

N2 - The gut hormones, cholecystokinin (CCK) and truncated glucagon-like peptide 1 (GLP-1(7-36)amide or GLP-1) both stimulate insulin secretion and affect glucagon secretion in mice, but their effects on the secretion of other islet hormones have not been established in rodents. In the present study, we have examined the influence of the C-terminal octapeptide of CCK, CCK-8, and GLP-1 on the secretion of pancreatic polypeptide (PP) in the mouse by the use of a radioimmunoassay for rodent PP. Mice were injected intravenously with CCK-8 (doses in the range of 0.053-5.3 nmol/kg) or with GLP-1 (doses in the range of 1-32 nmol/kg) and blood was sampled at 2, 6 or 10 min after the injection. Controls were injected with saline. It was found that CCK-8 at 5.3 nmol/kg increases plasma levels of both PP and insulin when the sample was taken at 2 min, but not at 6 or 10 min, after injection. These effects were blocked by the selective CCKA-receptor antagonist, L-364,718 (2.4 μmol/kg). GPL-1 increased plasma insulin levels at 32 nmol/kg at 2 and 6 min after the injection, but plasma PP levels were unaltered. In conclusion, this study, using a newly developed radioimmunoassay for PP in rodents, shows that CCK-8 but not GPL-1 stimulates PP secretion in mice at does levels where both peptides stimulate insulin secretion. Furthermore, PP secretion in response to CCK-8 showed a similarity with that of insulin in terms of dose- and time-response characteristics as well as sensitivity to CCKA-receptor antagonism.

AB - The gut hormones, cholecystokinin (CCK) and truncated glucagon-like peptide 1 (GLP-1(7-36)amide or GLP-1) both stimulate insulin secretion and affect glucagon secretion in mice, but their effects on the secretion of other islet hormones have not been established in rodents. In the present study, we have examined the influence of the C-terminal octapeptide of CCK, CCK-8, and GLP-1 on the secretion of pancreatic polypeptide (PP) in the mouse by the use of a radioimmunoassay for rodent PP. Mice were injected intravenously with CCK-8 (doses in the range of 0.053-5.3 nmol/kg) or with GLP-1 (doses in the range of 1-32 nmol/kg) and blood was sampled at 2, 6 or 10 min after the injection. Controls were injected with saline. It was found that CCK-8 at 5.3 nmol/kg increases plasma levels of both PP and insulin when the sample was taken at 2 min, but not at 6 or 10 min, after injection. These effects were blocked by the selective CCKA-receptor antagonist, L-364,718 (2.4 μmol/kg). GPL-1 increased plasma insulin levels at 32 nmol/kg at 2 and 6 min after the injection, but plasma PP levels were unaltered. In conclusion, this study, using a newly developed radioimmunoassay for PP in rodents, shows that CCK-8 but not GPL-1 stimulates PP secretion in mice at does levels where both peptides stimulate insulin secretion. Furthermore, PP secretion in response to CCK-8 showed a similarity with that of insulin in terms of dose- and time-response characteristics as well as sensitivity to CCKA-receptor antagonism.

KW - Cholecystokinin

KW - Glucagon-like peptide 1

KW - Mouse

KW - Pancreas

KW - Pancreatic polypeptide secretion

UR - http://www.scopus.com/inward/record.url?scp=0028789847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028789847&partnerID=8YFLogxK

U2 - 10.1016/0167-0115(95)00081-L

DO - 10.1016/0167-0115(95)00081-L

M3 - Article

C2 - 8577934

AN - SCOPUS:0028789847

VL - 59

SP - 297

EP - 302

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 3

ER -